Paric A, Tomic K, Alidzanovic L, Fojnica A, Vranic S
Acta Med Acad. 2024; 53(3):237-273.
PMID: 39655353
PMC: 11831570.
DOI: 10.5644/ama2006-124.458.
Rebolj M, Brentnall A, Cuschieri K
Br J Cancer. 2024; 130(11):1733-1743.
PMID: 38615108
PMC: 11130303.
DOI: 10.1038/s41416-024-02681-z.
Wang W, Arca E, Sinha A, Hartl K, Houwing N, Kothari S
Prev Med Rep. 2022; 28:101813.
PMID: 35637896
PMC: 9142642.
DOI: 10.1016/j.pmedr.2022.101813.
Ignat R, Coza D, Ignat P, Badea R, Suteu O
Curr Oncol. 2021; 28(3):1706-1717.
PMID: 33946336
PMC: 8161806.
DOI: 10.3390/curroncol28030159.
Wojtyla C, Ciebiera M, Kowalczyk D, Panek G
Int J Environ Res Public Health. 2020; 17(13).
PMID: 32605159
PMC: 7369878.
DOI: 10.3390/ijerph17134639.
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
Kyrgiou M, Arbyn M, Bergeron C, Bosch F, Dillner J, Jit M
Br J Cancer. 2020; 123(4):510-517.
PMID: 32507855
PMC: 7434873.
DOI: 10.1038/s41416-020-0920-9.
Over Expressed TKTL1, CIP-2A, and B-MYB Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients.
Chiarini A, Liu D, Rassu M, Armato U, Eccher C, Dal Pra I
Front Oncol. 2019; 9:213.
PMID: 31001477
PMC: 6456695.
DOI: 10.3389/fonc.2019.00213.
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.
Chrysostomou A, Stylianou D, Constantinidou A, Kostrikis L
Viruses. 2018; 10(12).
PMID: 30572620
PMC: 6315375.
DOI: 10.3390/v10120729.
Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.
Roik E, Nieboer E, Kharkova O, Grjibovski A, Postoev V, Odland J
Int J Environ Res Public Health. 2017; 14(12).
PMID: 29186874
PMC: 5750918.
DOI: 10.3390/ijerph14121500.
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Baldauf J, Fender M, Bergeron C, Marrer E, Velten M, Pradat P
Eur J Cancer Prev. 2017; 28(1):33-39.
PMID: 29135538
PMC: 6296848.
DOI: 10.1097/CEJ.0000000000000415.
Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program.
Maggino T, Sciarrone R, Murer B, Dei Rossi M, Fedato C, Maran M
Br J Cancer. 2016; 115(5):525-32.
PMID: 27490801
PMC: 4997543.
DOI: 10.1038/bjc.2016.216.
A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium.
Tjalma W, Trinh X, Rosenlund M, Makar A, Kridelka F, Rosillon D
Facts Views Vis Obgyn. 2015; 7(2):101-8.
PMID: 26175888
PMC: 4498167.
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A, Cybulski M, Sliwczynski A, Chil A, Teter Z, Seroczynski P
BMC Cancer. 2015; 15:279.
PMID: 25879466
PMC: 4417537.
DOI: 10.1186/s12885-015-1242-9.
Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).
Arbyn M, Fabri V, Temmerman M, Simoens C
PLoS One. 2014; 9(4):e92615.
PMID: 24690620
PMC: 3972167.
DOI: 10.1371/journal.pone.0092615.
[Involvement of general practitioners in the province Benimellal (Morocco) in screening for cervical cancer].
Nani S, Benallal M, Hassoune S, Kissi D, Maaroufi A
Pan Afr Med J. 2013; 14:152.
PMID: 23785557
PMC: 3683513.
DOI: 10.11604/pamj.2013.14.152.2570.
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch P
Cochrane Database Syst Rev. 2013; (3):CD008054.
PMID: 23543559
PMC: 6457841.
DOI: 10.1002/14651858.CD008054.pub2.
Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study.
Mennini F, Baio G, Montagano G, Cauzillo G, Locuratolo F, Becce G
BMJ Open. 2012; 2(2):e000736.
PMID: 22422918
PMC: 3307037.
DOI: 10.1136/bmjopen-2011-000736.
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document.
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N
Ann Oncol. 2010; 21(3):448-458.
PMID: 20176693
PMC: 2826099.
DOI: 10.1093/annonc/mdp471.
Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy.
Rossi P, Ricciardi A, Cohet C, Palazzo F, Furnari G, Valle S
BMC Public Health. 2009; 9:71.
PMID: 19243586
PMC: 2651166.
DOI: 10.1186/1471-2458-9-71.
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate.
Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J
J Cell Mol Med. 2009; 13(4):648-59.
PMID: 19166485
PMC: 3822872.
DOI: 10.1111/j.1582-4934.2008.00631.x.
